{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:44:18Z","timestamp":1793681058454,"version":"4.5.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.genhosppsych.2008.02.002","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T04:58:20Z","timestamp":1216875500000},"page":"471-475","source":"Crossref","is-referenced-by-count":50,"title":["Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review"],"prefix":"10.1016","volume":"30","author":[{"given":"Beatriz","family":"Arbaizar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"G\u00f3mez-Acebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2008.02.002_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/14737175.6.1.19","article-title":"Topiramate for the treatment of epilepsy and other nervous system disorders","volume":"6","author":"van Passel","year":"2006","journal-title":"Expert Rev Neurotherapeutics"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","article-title":"Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial","volume":"61","author":"Johnson","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib3","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib4","first-page":"1","article-title":"Targets for antiepileptic drugs in the synapse","volume":"13","author":"Johannessen Landmark","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","article-title":"Relations between mechanisms of action and clinical efficacy of antiepileptic drugs in non-epilepsy conditions","volume":"22","author":"Johannessen Landmark","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity","volume":"1","author":"Bray","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects","volume":"28","author":"Wilding","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2003.08.032","article-title":"Dual roles in feeding for AMPA\/kainite receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior","volume":"992","author":"Hettes","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Nickel","year":"2005","journal-title":"Int J Eat Disord"},{"issue":"suppl","key":"10.1016\/j.genhosppsych.2008.02.002_bib11","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/eat.10207","article-title":"Pharmacologic treatment of binge eating disorder","volume":"34","author":"Carter","year":"2003","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopsych.2005.03.001","article-title":"Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Grilo","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","article-title":"Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial","volume":"160","author":"McElroy","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02850181","article-title":"Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenalin, in the treatment of binge eating disorder: a placebo-controlled study","volume":"22","author":"Milano","year":"2005","journal-title":"Adv Ther"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archpsyc.60.11.1109","article-title":"A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder","volume":"60","author":"Appolinario","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1176\/appi.ajp.2007.06121970","article-title":"Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study","volume":"165","author":"Wilfley","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib17","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.4088\/JCP.v67n1209","article-title":"Zonisamide in the treatment of binge eating disorder with obesity: a placebo-controlled trial","volume":"67","author":"McElroy","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4088\/JCP.v68n0306","article-title":"Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial","volume":"68","author":"McElroy","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4088\/JCP.v68n0901","article-title":"Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive\u2013behavior therapy in binge-eating disorder","volume":"68","author":"Claudino","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial: Part 1. Improvement in binge and purge measures","volume":"64","author":"Hoopes","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-8993(93)90458-Y","article-title":"II. Lateral hypothalamic injections of glutamate, kainic acid, d,l-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic or N-methyl-d-aspartic acid rapidly elicit intense transient eating in rats","volume":"613","author":"Stanley","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainres.2007.09.060","article-title":"Stimulation of lateral hypothalamic kainate receptors selectively elicits feeding behavior","volume":"1184","author":"Hettes","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4088\/JCP.v61n0508","article-title":"Treatment of binge-eating disorder with topiramate: a clinical case series","volume":"61","author":"Shapira","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/070674370204700309","article-title":"Topiramate use in obese patients with binge eating disorder: an open study","volume":"47","author":"Appolinario","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.v65n1104","article-title":"Topiramate in the long-term treatment of binge-eating disorder associated with obesity","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2008.02.002_bib27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834308000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834308000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T18:29:14Z","timestamp":1557685754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834308000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0163834308000315"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2008.02.002","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}